Inex Pharmaceuticals Corp., of Vancouver, British Columbia, appointed Gary Frashier and James Hudson to its board.

Ingenium Pharmaceuticals AG, of Munich, Germany, added Klaus Dembowsky as vice president, drug discovery.

Inhibitex Inc., of Atlanta, elected Louis Sullivan and Marc Preminger to its board.

Inspire Pharmaceuticals Inc., of Durham, N.C., appointed Kenneth Lee to its board.

Integrated Pharmaceuticals Inc., of Boston, appointed Richard Schoenfeld vice president, marketing and business development.

Invitrogen Corp., of Carlsbad, Calif., appointed Claude Benchimol senior vice president of research and development.

Lipid Sciences Inc., of Pleasanton, Calif., appointed Susan Zolla-Pazner to its viral advisory board.

MedImmune Inc., of Gaithersburg, Md., promoted Edward Arcuri to senior vice president, manufacturing operations; William Bertrand to vice president, general counsel and corporate compliance officer; Peter Kiener to vice president, research; Bernardus Machielse to senior vice president, quality; and Caroline York to vice president, government affairs and reimbursement. David Robinson was added as vice president, oncology sales and marketing.